Good practice guideline: Promoting Early Identification of Systemic Anti-Cancer Therapies Side Effects: – Two Approaches.
Intended for healthcare professionals
Clinical feature Previous     Next

Good practice guideline: Promoting Early Identification of Systemic Anti-Cancer Therapies Side Effects: – Two Approaches.

This guidance has been produced by the National Chemotherapy Board in response to concerns that patients often delay reporting serious Systemic Anti-Cancer Therapy (SACT) side effects to dedicated help lines. Two complementary approaches to improve side effect reporting are suggested:

Empowerment focuses on equipping patients to take responsibility for identifying and reporting important side effects and may be mediated via technology.

Proactive monitoring includes clinician interventions (e.g. telephone support or home visits).

Cancer Nursing Practice. 15, 9, 19-22. doi: 10.7748/cnp.15.9.19.s20

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more